Black Swan Pharmaceuticals
Focus: Black Swan Pharmaceuticals is a public-stage biotech focused on antisense RNA-based therapeutics for ALS and other neurological conditions. The company is headquartered in Wake Forest, NC and operates as a specialized gene therapy platform.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
5
Should You Work at Black Swan Pharmaceuticals?
AI assessmentBlack Swan is a speculative opportunity for mission-driven scientists seeking impact in ALS therapeutics, but limited hiring and pipeline visibility pose material career risk.
Why Work Here
- Focused R&D model in high-impact neurology space (ALS) with proven modality (antisense RNA therapeutics)
- Public company status provides equity liquidity and institutional stability compared to early-stage ventures
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Clinical follow-up 1
Monoclonal Gammopathy of Undetermined SignificanceOpen Jobs (5)
Help build intelligence for Black Swan Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.